Accuray (ARAY) Competitors $1.36 -0.05 (-3.55%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.36 0.00 (0.00%) As of 07/11/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, BSX, SYK, and MDTShould you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry. Accuray vs. Its Competitors Orthofix Medical Surmodics AngioDynamics Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Orthofix Medical (NASDAQ:OFIX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings. Which has more risk & volatility, OFIX or ARAY? Orthofix Medical has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Accuray has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Which has stronger valuation & earnings, OFIX or ARAY? Accuray has lower revenue, but higher earnings than Orthofix Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrthofix Medical$799.49M0.54-$126M-$3.69-2.99Accuray$446.55M0.31-$15.55MN/AN/A Do insiders and institutionals have more ownership in OFIX or ARAY? 89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 1.3% of Orthofix Medical shares are held by company insiders. Comparatively, 4.2% of Accuray shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is OFIX or ARAY more profitable? Accuray has a net margin of 0.14% compared to Orthofix Medical's net margin of -17.78%. Accuray's return on equity of 1.43% beat Orthofix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Orthofix Medical-17.78% -28.15% -16.51% Accuray 0.14%1.43%0.14% Do analysts prefer OFIX or ARAY? Orthofix Medical presently has a consensus price target of $21.50, suggesting a potential upside of 94.57%. Given Orthofix Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Orthofix Medical is more favorable than Accuray.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Accuray 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to OFIX or ARAY? In the previous week, Orthofix Medical had 1 more articles in the media than Accuray. MarketBeat recorded 5 mentions for Orthofix Medical and 4 mentions for Accuray. Orthofix Medical's average media sentiment score of 1.67 beat Accuray's score of 1.02 indicating that Orthofix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Accuray 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOrthofix Medical beats Accuray on 9 of the 15 factors compared between the two stocks. Get Accuray News Delivered to You Automatically Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ARAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARAY vs. The Competition Export to ExcelMetricAccurayMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$140.10M$6.73B$5.56B$9.11BDividend YieldN/A1.28%5.06%4.01%P/E RatioN/A26.3028.2620.26Price / Sales0.3185.55437.10166.10Price / CashN/A20.3337.1257.67Price / Book3.024.648.045.49Net Income-$15.55M$174.76M$3.19B$250.45M7 Day Performance-4.49%-1.00%3.62%4.79%1 Month Performance11.48%0.99%5.98%9.59%1 Year Performance-30.96%5.27%29.39%16.41% Accuray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARAYAccuray2.7762 of 5 stars$1.36-3.5%N/A-31.0%$140.10M$446.55M0.001,040Positive NewsOFIXOrthofix Medical3.0373 of 5 stars$10.72-3.6%$21.50+100.6%-29.9%$435.69M$799.49M-2.911,616SRDXSurmodics4.3629 of 5 stars$29.66-1.1%$43.00+45.0%-26.8%$428.83M$126.08M-21.34450ANGOAngioDynamics3.9081 of 5 stars$9.19-4.1%$14.00+52.3%+55.3%$389.02M$303.91M-9.10760News CoverageUpcoming EarningsRMTIRockwell Medical4.1489 of 5 stars$0.80-3.1%$4.00+401.9%-46.9%$28.12M$101.49M0.00300Positive NewsRSLSReShape Lifesciences0.3801 of 5 stars$2.38+0.4%N/A-99.2%$5.65M$8.01M-0.0150ABTAbbott Laboratories4.9542 of 5 stars$133.62-0.6%$142.61+6.7%+26.5%$233.90B$42.34B17.33114,000Trending NewsUpcoming EarningsAnalyst ForecastISRGIntuitive Surgical4.6774 of 5 stars$534.71-1.8%$588.95+10.1%+15.3%$195.15B$8.35B78.4015,638Positive NewsAnalyst ForecastBSXBoston Scientific4.6488 of 5 stars$103.75-0.5%$116.09+11.9%+32.8%$154.34B$16.75B75.7353,000Trending NewsSYKStryker4.7996 of 5 stars$392.26-0.8%$427.30+8.9%+14.7%$150.87B$22.60B53.0153,000Positive NewsAnalyst ForecastMDTMedtronic4.6142 of 5 stars$87.73-0.7%$97.87+11.6%+15.5%$113.36B$33.54B24.2395,000Trending NewsAnalyst ForecastGap Up Related Companies and Tools Related Companies OFIX Alternatives SRDX Alternatives ANGO Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives ISRG Alternatives BSX Alternatives SYK Alternatives MDT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ARAY) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accuray Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Accuray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.